Taiwan FDA registration e23d8e18d88b92ac350a5716d33ef36f

Free light chain kaba analysis group dedicated to the Bondis SPAPLUS model

TW: 邦迪斯SPAPLUS機型專用自由輕鏈卡巴分析組

Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered Nov 17, 2010 – Nov 17, 2025Expired

Registration details

Analysis ID: e23d8e18d88b92ac350a5716d33ef36f
Customs Code: DHA00602180302

Company information

Manufacturer: THE BINDING SITE GROUP LIMITED
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: This set can be used for the quantitative analysis of free Kappa light chains in serum by the Binding Site SPAPLUS model.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5550 Immunoglobulin (Specific Light Chain) Immunoassay System
Import Information: import

Dates and status

Registration Date: Nov 17, 2010
Expiry Date: Nov 17, 2025

About this record

Access comprehensive regulatory information for Free light chain kaba analysis group dedicated to the Bondis SPAPLUS model in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e23d8e18d88b92ac350a5716d33ef36f and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.